Indication
pleural effusion
11 clinical trials
12 products
1 drug
Clinical trial
A Translational Phase 1/2 Dose-Escalation and Expansion Study to Determine Safety, Tolerability, and Recommended Phase 2 Dose of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including MesotheliomaStatus: Recruiting, Estimated PCD: 2025-04-01
Product
RSO-021Clinical trial
A Phase 2, Randomized, Placebo-controlled, Double-blind, Dose-ranging Study Evaluating LTI-01 (Single-chain Urokinase Plasminogen Activator, scuPA) in Patients With Infected, Non-draining Pleural EffusionsStatus: Completed, Estimated PCD: 2022-03-31
Product
PlaceboProduct
LTI-01Clinical trial
Prospective Randomized Double-Blind Controlled Trial of Intrapleural Fibrinolytic Therapy to Enhance Chemical PleurodesisStatus: Completed, Estimated PCD: 2023-12-14
Product
Cathflo ActivaseProduct
Talc SlurryClinical trial
Single-arm Open Multicenter Study of IFN-γ Combined With T Cells in the Treatment of Refractory Malignant Pleural Effusion TumorsStatus: Recruiting, Estimated PCD: 2024-12-30
Product
IFN-γ and CIK cellsClinical trial
Efficacy of Topical Lidocaine/Prilocaine in Pain Management in PleurocentesisStatus: Recruiting, Estimated PCD: 2023-09-01
Product
Lidocaine + PrilocaineClinical trial
Creation of a Pleural Carcinomatosis Tissue BankStatus: Recruiting, Estimated PCD: 2024-11-17
Clinical trial
Thoracentesis to Alleviate Cardiac Pleural Effusion - an Interventional Trial (TAP-IT)Status: Recruiting, Estimated PCD: 2023-12-01
Product
Standard-of-careClinical trial
Safety And Efficacy Of 8 Hourly Normal Saline Flushing With And Without Heparin Lock In Maintaining Small Bore Intercostal Chest Catheter (ICC) Patency ; A Prospective Pilot StudyStatus: Recruiting, Estimated PCD: 2027-03-01
Product
HeparinClinical trial
A Phase II Trial of Intrapleural Instillation of the Nivolumab in Cancer Patients With Pleural Effusion.Status: Completed, Estimated PCD: 2023-03-01
Drug
T-VECClinical trial
Phase I Study of Specific CAR-T Dual-targeting HER2 and PD-L1 in Patients With Pleural or Peritoneal Metastasis of HER2 Positive CancerStatus: Recruiting, Estimated PCD: 2024-12-30
Clinical trial
Persistent Pleural Effusion Treatment Following Cardiothoracic Surgery by Platelet-Fibrin Glue: A Clinical TrailStatus: Completed, Estimated PCD: 2023-05-01
Product
Platelet-Rich Plasma